Published in Medical Letter on the CDC and FDA, November 27th, 2005
The second wave of the quarterly survey, completed in September, concluded that very few of the key measures that were reported on in June have changed significantly.
"The presidential speeches and early promotions have had little effect over the summer," said DSS President and CEO Roger Gates. "Our September national survey shows Part D awareness high, but familiarity, knowledge, and purchase intent are low - virtually unchanged from the results we...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.